National Glaucoma Society: Topics

Case of the Month

Topics: What's Worse Than a Migraine?; Angle Closure Glaucoma and Topomax; Uveitic Glaucoma; Episodic Damage to the RNFL; The Importance of Risk Factors for Younger Patients; Glaucoma and Retinal Pathologies; Bilateral NAION; Neuroretinal Rim Defects; Optic Neuritis; Iridotomy; Angle Closure Due to Topamax; Iridotomy Part II: Was It Successful?; Uveitis and Elevated IOP; Is This Glaucoma?; Anomalous Optic Nerve; Asymmetry; Detecting Visual Field Progression in Glaucoma; Ganglion Cell Analysis and Visual Fields; Glaucoma Masqueraders; Unusual Side Effect of Topical Glaucoma Medication; Angle Recession; IOL Iris Defect; Glaucoma Damage in a Younger Patient; OCT and Ocular Lesions; Monitoring Conjuctival Lesions; Visual Fields vs. Optic Nerve Imaging; Sjogren's Syndrome; Duane's Retraction Syndrome; "Regular" Iritis; NAION; Giant Cell Arteritis; Complicated Uveitis; Central Serous Retinopathy; Doyne's Honeycomb Dystrophy; Vascular Issues in Glaucoma; SLT as First Line Therapy; RNFL Changes on OCT; Anomalous Optic Discs; Large Cupping vs Glaucoma; NTG and Disc Hemorrhages; Angle Closure and Cataracts; Durysta Glaucoma Implant Surgery; Pseudoexfoliation Glaucoma; Surgical Intervention for Exfoliative Glaucoma; Classic POAG; Is This Glaucoma?; Asymmetric Glaucoma; Laser PI; Low Tension Glaucoma; Treatment Options for Progression; Glaucoma Surgery and OSD; Glaucoma and Cataract Surgery; Decision to Treat or Not; Uveitic Glaucoma; Is it Glaucoma?; Asymmetric IOPs; Normal Tension Glaucoma; Secondary Glaucoma from Ocular Trauma; Normal Tension Glaucoma Patient; SLT as First-Line Therapy; Uveitic Glaucoma and Autoimmune Disease; New Glaucoma Evaluation

Webinars

Topics: Cirrus HD-OCT Technology; Why Measure the Macula in Glaucoma; Clinical Pearls from The OHTS Study; Instructions for NGS Webinars on WebEx; Fluctuations in IOP; Getting WebEx for Your Smart Phone or Tablet; Optic Nerve Evaluation; Insights into the Use of Technology: Glaucoma Change Over Time; The Use of OCTs in Glaucoma; Will the Real IOP Please Stand Up; Using Chat During a Webinar; Ganglion Cell Analysis; Disc Hemorrhage; Peripapillary Atrophy; Patient Compliance; Using A Smart Phone for Webinars; Managing Ocular Pain; Sleep Apnea; Swollen Optic Nerves; OCT: The Optometrist's MREye; Influences on IOP; Corneal Hysteresis Measurement; Using an OCT to Detect Progression; Diabetic Retinopathy and Omega-3s; Stem Cell Technology; Checking on Prior Registrations; Fundus Autofluorescence; Hyperosmolar Eye Drops and Fuch's Disease
Discussions: Re: Getting WebEx for Your Smart Phone or Tablet; sign up for Nov 18 webinar; Re: Getting WebEx for Your Smart Phone or Tablet; No, the chat window is part of the WebEx video conferencing. You need to enable it once you are on the webinar by clicking on the grey speech bubble in
read more; Re: Getting WebEx for Your Smart Phone or Tablet; I cant seem to get the chat window open? Is this the same?

Industry News

Topics: New FDA Approval for Lumigan; Alcon's Travatan Z Solution Receives FDA Approval; Alcon's Travatan Z and Systane Use Different Preservatives; Pfizer Sponsors New "All Eyes on Glaucoma" Website; CLIA Waivers; Bausch + Lomb New Glaucoma Drug; Glaukos iStent inject FDA Approved; Alcon Withdraws CyPass Stents; Nuretin Omega-3 Supplements; Rocklatan FDA Approved; Vivid Vision Perimetry; Falck Multifunction Device; Zeiss Medical Device Recall; Sustained IOP Reduction with iDose TR
Discussions: Re: Rocklatan FDA Approved; Curious, I just started a patient (my first with this therapy) on Rocklatan after getting ZERO IOP change on generic Xalatan. He has been using it correctly for no more
read more; Re: Alcon's Travatan Z Solution Receives FDA Approval; Dr. Ghosh, If you click on the Alcon logo on the lower right side of this website, it will bring you to Alcon's Travatan website where there is complete product information
read more; Re: Alcon's Travatan Z Solution Receives FDA Approval; I would like to receive some full text about the new approved drug Travatan Z

Clinical Guidelines

Topics: CCT: Is is time to say YES?; The Role of CCT in Glaucoma Patients; More CCT; The Paradox of IOP; Should We Treat All Ocular Hypertensives?; Beta Blockers in Glaucoma Management; Re-Defining Ocular Hypertension; Implications of Macro-Disc Asymmetry in Glaucoma Suspects; Nine-Year Changes in Intraocular Pressure: The Barbadoes Eye Studies; CyPass Clinical Recommendations; Optic Disc Cupping and Neuroimaging
Discussions: Re: The Paradox of IOP; At a recent education event one of our attendees asked me to find out the incidence of ocular hypertension in the general population. I could not identify a study noting
read more

Pharmacology Update

Topics: Extravan: Alcon Pharmaceuticals; Mechanism of IOP Reduction with Travoprost; Floater Intervention Study; Nanodropper; Chart of Glaucoma Therapies; Hydroxychloroquine Toxicity; Timolol; Upneeq Drops for Ptosis; Tetracaine Study
Discussions: Re: Nanodropper; /Dr. H, not sure how you would get the drop out of bottle if you put a nano dropper on it, i would think that you would need to squeeze
read more; Re: Nanodropper; I would use it for fluress(and other brands for Goldmann tonkmetry),considering their crazy high prices but I am not sure if the nanodropper tip would fit the glass bottles.; Re: Nanodropper; I would be curious if anyone else is using this tech. We ordered a few samples to use in our clinic, with our dilating drops, but I have yet
read more

In Your Office

Topics: Glaucoma Flowsheet; Tonometer Calibration; Pachymetry Coding; BCBS Coverage of SCODI Services; Expanded Coverage of Glaucoma Screening Services; Coding Update: 92135 Deleted and Replaced; ABO Certification Review Materials; Small Fee Reduction in CMS Payments in 2015; Moist Heat Compresses; Information about Omega-3s; Lighthizer Surgical Procedure Set; Glaucoma Website for Patients; Beware of Phone Scam Posing as DPH or DEA; Tonography; Patient Assistance Programs; Plaquenil Reporting Form; World Optometry Day
Discussions: Re: Moist Heat Compresses; You also discussed information and possible group pricing about a gland expresser and said you would provide information regarding that instrument. Please post that information. Thank you.; Re: ABO Certification Review Materials; Could you please send the glaucoma review information and uveitis labs worksheets to lmillod@ptd.net.; Re: ABO Certification Review Materials; I also attended the SECO course, could you please email the ABO certification review material to davidfierceod@yahoo.com. Thanks!

Glaucoma Watch

Topics: Interesting Glaucoma Cases; From Ocular Hypertension to Glaucoma: How to Predict Conversion; Neckties and IOP: The Controversy Continues; Introduction to the National Glaucoma Society; Case Presentation: Optic Nerve Imaging; NGS Residency Award and Lecture; Optic Nerve Head Measurements with the HRT III; Case Presentation: Laser Imaging Detects Early ON Damage; Is the Optic Disc "Sinking" or "Cupping" in Glaucoma?; Interview with Dr. Barry Barresi; Glaucoma Continuum; Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study; The Prevalence of Open-angle Glaucoma Among Blacks and Whites 73 Years and Older; Altered Nitric Oxide System in Patients with Open-Angle Glaucoma; Oxidative Stress in Glaucoma: A Burden of Evidence; Gonioscopy Videos; Glaucoma Risk and the Consumption of Fruits and Vegetables in Older Women; Programs to Optimize Adherence in Glaucoma; Corneal Hysteresis; Treatment Goals in Glaucoma; Visual Field Interpretation; Study Questions link between Glaucoma and Alzheimer's Disease; Checking Color Vision; Glaucoma Medications; IOP Asymmetry as Glaucoma Risk Factor; Glaucoma Risk Calculators; Dr. David Calkins Discusses Catalyst for A Cure; Smart Phone Biosensor; Handheld OCT; Sustained Release IOP Therapies; Introduction to Corneal Hysteresis; FDT Perimetry; Visual Fields Overview; National Glaucoma Symposium 2017; Gonioscopy Slides from 2017 National Glaucoma Symposium; Measuring Corneal Hysteresis; XEN Glaucoma Implant Video; Corneal Hysteresis; Glaucoma Quality of Life Measures; Corneal Hysteresis: The A1C of Glaucoma; Predicting Progression; New Developments in Glaucoma Management; Longitudinal Study of Corneal Hysteresis; National Glaucoma Symposium 2018; DREAM Study; OIS at SECO; National Glaucoma Symposium Cape Cod; Is Glaucoma a Two-Pressure Disease?; ICD Stage Definitions; Visual Fields and Progression; OCT: The Basics; Co-Managing Glaucoma Surgery; Normal Tension Glaucoma; The Importance of Visual Fields; Corneal Hysteresis; Using OCT in Glaucoma Management; The LiGHT Study; Durysta Overview; Options in Glaucoma Surgery; Telemedicine in Glaucoma; Glaucoma Medications; New Visual Field Primer; Glaucoma Risk Factors; Drug Therapy for the Ocular Surface in Glaucoma; OCT Overview and Applications; Yoga as Adjunct Glaucoma Therapy; Cataract Surgery May Lower Risk for Dementia; Parapapillary Atrophy; Angle Closure Glaucoma; Congratulations to Dr. Thimons; Corneal Influences on IOP
Discussions: Re: Longitudinal Study of Corneal Hysteresis; Great article, Jim, thanks.; Re: National Glaucoma Symposium 2011; Another successful conference! See you next year July 28-30, 2012.; Re: Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study; In reading the details found within the journal article highlighted above, it is evident that significant efforts must be made to educate the population better as to the risks of
read more

Your Registrations

You have no registrations currently in your cart.

News

NGS WEBINARS 2025

Webinars will begin in January 2025. Happy Thanksgiving

NGS PROGRAMS FALL 2023

The NGS Wednesday webinars will begin on September 13 with two webinars a month in September through December. There also will be an in-person program on October 8 in Malvern, PA with 8 hours of CE. All programs will be submitted for COPE approval. (Please Note: There are no NGS programs this summer.)

NGS WEBINARS SPRING 2023

NGS webinars will take place twice a month in March to May, 2023, followed by a break from the webinars over the summer.

NEW HAMPSHIRE INDICATES LIVE WEBINARS = FORMAL CE

The New Hampshire Board of Optometry announced in August 2022 that courses approved by COPE are automatically approved as Class I Formal CE. In addition, they clarified that live webcasts with real-time active participation by attendees are Formal CE, the same as in-person programs. In contrast, Alternative CE refers to lectures that are not live. More details are on the NH Board of Optometry website under Laws and Rules, Standing Orders.

COPE RULES FOR INTERACTIVE WEBINARS 2023

As of January 2023, COPE will include interactive webinars in the same category as in-person lectures, with no post-test required. CE will be categorized as either Synchronous (lecturer and learner are together at the same time, either in-person or virtually, with real-time communication) or Asynchronous (lecturer and learner are not together at same time, no real-time communication). Interactive webinars will be labeled Synchronous Virtual CE for courses and activities submitted after January 1 (interactive webinars approved before January 1 may still be labeled Online Interactive courses or Interactive Distance Learning events). Please Note: State Boards may restrict the number of Synchronous Virtual hours of CE allowed for license renewal; check with your State Board for the latest regulations.

LIVE WEBINARS = LIVE CE IN MASSACHUSETTS

At their December 15, 2021 meeting, the Massachusetts Board of Optometry specified that a live webinar where speakers and attendees can interact in real-time are considered to be live CE. The Board clarified that distance learning CE courses, which are limited to 6 hours per renewal cycle, are those where the licensees are reading content or observing media on their own with no interaction with the instructor. Thus, the COPE-approved interactive NGS webinars count as live CE for MA optometrists.

CE BROKER FOR TEXAS OPTOMETRISTS

The NGS will submit attendance data to CE Broker for Texas optometrists who attend our webinars. We will continue to mail CE certificates so attendees have a copy for their records and also will send attendance data to ARBO's OE Tracker.

PENNSYLVANIA CE REGULATIONS

The Pennsylvaia Board of Optometry will allow all CE to be online for the renewal period that ends November 30, 2022. Starting December 1, 2022, revised regulations allow for up to 50% of the CE requirements (15 out of 30 ours) to be online.

CALIFORNIA ALLOWS LIVE WEBINARS AS LIVE CE

The California Board of Optometry now recognizes interactive courses offered live over internet platforms such as WebEx as Live CE toward the 30 hours of live continuing education required for license renewal. Courses can be live COPE courses offered by COPE's June 30, 2021 deadline or courses approved by the Board.

Join Our Email List

National Glaucoma Society